$1.91
10.33% today
Nasdaq, Sep 25, 07:44 pm CET
ISIN
US86272A2069
Symbol
SSKN

STRATA Skin Sciences, Inc. Stock price

$2.13
+0.44 26.04% 1M
-0.44 17.12% 6M
-0.78 26.80% YTD
-0.93 30.39% 1Y
-5.77 73.04% 3Y
-11.82 84.73% 5Y
-56.87 96.39% 10Y
-3,852.87 99.94% 20Y
Nasdaq, Closing price Wed, Sep 24 2025
-0.46 17.76%

Key metrics

Basic
Market capitalization
$11.2m
Enterprise Value
$19.9m
Net debt
$8.7m
Cash
$6.5m
Shares outstanding
4.2m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
0.3 | 0.3
EV/Sales
0.6 | 0.6
EV/FCF
negative
P/B
4.2
Financial Health
Equity Ratio
13.8%
Return on Equity
-202.9%
ROCE
-43.8%
ROIC
-37.9%
Debt/Equity
5.7
Financials (TTM | estimate)
Revenue
$33.6m | $33.2m
EBITDA
$-3.1m | $2.3m
EBIT
$-8.4m | $-5.6m
Net Income
$-9.2m | $-7.0m
Free Cash Flow
$-670.0k
Growth (TTM | estimate)
Revenue
3.3% | -1.2%
EBITDA
28.0% | 2,657.8%
EBIT
14.6% | -3.3%
Net Income
19.5% | 30.8%
Free Cash Flow
85.0%
Margin (TTM | estimate)
Gross
58.4%
EBITDA
-9.3% | 6.9%
EBIT
-24.9%
Net
-27.2% | -21.1%
Free Cash Flow
-2.0%
More
EPS
$-2.2
FCF per Share
$-0.2
Short interest
3.7%
Employees
106
Rev per Employee
$320.0k
Show more

Is STRATA Skin Sciences, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,008 stocks worldwide.

STRATA Skin Sciences, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a STRATA Skin Sciences, Inc. forecast:

7x Buy
88%
1x Hold
13%

Analyst Opinions

8 Analysts have issued a STRATA Skin Sciences, Inc. forecast:

Buy
88%
Hold
13%

Financial data from STRATA Skin Sciences, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
34 34
3% 3%
100%
- Direct Costs 14 14
9% 9%
42%
20 20
15% 15%
58%
- Selling and Administrative Expenses 23 23
4% 4%
70%
- Research and Development Expense 0.74 0.74
40% 40%
2%
-3.11 -3.11
28% 28%
-9%
- Depreciation and Amortization 5.27 5.27
4% 4%
16%
EBIT (Operating Income) EBIT -8.38 -8.38
15% 15%
-25%
Net Profit -9.15 -9.15
20% 20%
-27%

In millions USD.

Don't miss a Thing! We will send you all news about STRATA Skin Sciences, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

STRATA Skin Sciences, Inc. Stock News

Neutral
GlobeNewsWire
3 days ago
Investigator-initiated randomized controlled combination trial published in the International Journal of Dermatology confirms its superiority to monotherapy, fueling continued market growth and expanding indications Investigator-initiated randomized controlled combination trial published in the International Journal of Dermatology confirms its superiority to monotherapy, fueling continued marke...
Neutral
GlobeNewsWire
21 days ago
HORSHAM, Pa., Sept. 04, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (Nasdaq: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced the closing of its previously announced registered direct offering for the issuance and sale of 1,097,547 shar...
Neutral
GlobeNewsWire
21 days ago
Consulting program optimizes partner clinic businesses with implementation of best practices initiatives, including marketing, reimbursement, and patient retention Consulting program optimizes partner clinic businesses with implementation of best practices initiatives, including marketing, reimbursement, and patient retention
More STRATA Skin Sciences, Inc. News

Company Profile

STRATA Skin Sciences, Inc. is a medical technology company in Dermatology and Plastic Surgery. It engages in developing, commercializing and marketing products for the treatment of dermatologic conditions. The firm operates through the following segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. The Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. The company was founded by Dina Gutkowicz-Krusin in December 1989 and is headquartered in Horsham, PA.

Head office United States
CEO Dolev Rafaeli
Employees 106
Founded 1989
Website www.strataskinsciences.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today